• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    9.01 0.23(2.62%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:8.78
    Open:8.84
    Bid:7.11 x 100
    Ask:9.64 x 500
    1y Target Est:21.00
    Beta:4.65
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:8.80 - 9.08
    52wk Range:7.48 - 15.80
    Volume:629,615
    Avg Vol (3m):1,134,860
    Market Cap:545.92M
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INO

    Comparison

    Symbol% ChgMkt Cap
    INOUp 2.62%545.92M
    AZN91.07B
    PFE201.43B
    SNY122.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):54.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.61
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback